These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30684452)

  • 1. Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?
    Elgendy IY; Pepine CJ
    Am J Med; 2019 Jun; 132(6):692-697. PubMed ID: 30684452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure with preserved ejection fraction in hypertension.
    Teo LY; Chan LL; Lam CS
    Curr Opin Cardiol; 2016 Jul; 31(4):410-6. PubMed ID: 27070649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction.
    Srivaratharajah K; Coutinho T; deKemp R; Liu P; Haddad H; Stadnick E; Davies RA; Chih S; Dwivedi G; Guo A; Wells GA; Bernick J; Beanlands R; Mielniczuk LM
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction.
    Weerts J; Mourmans SGJ; Barandiarán Aizpurua A; Schroen BLM; Knackstedt C; Eringa E; Houben AJHM; van Empel VPM
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Sinha A; Rahman H; Webb A; Shah AM; Perera D
    Eur Heart J; 2021 Nov; 42(43):4431-4441. PubMed ID: 34529791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction.
    Tona F; Montisci R; Iop L; Civieri G
    Rev Cardiovasc Med; 2021 Mar; 22(1):97-104. PubMed ID: 33792251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report.
    Joung S; Wei J; Nelson MD; Aldiwani H; Shufelt C; Tamarappoo B; Berman D; Thomson LEJ; Bairey Merz CN
    J Med Case Rep; 2019 May; 13(1):134. PubMed ID: 31056078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular dysfunction in patients with heart failure with preserved ejection fraction: A meta-analysis.
    Azuma M; Kato S; Fukui K; Horita N; Utsunomiya D
    Microcirculation; 2023 Oct; 30(7):e12822. PubMed ID: 37491798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction.
    Chandramouli C; Ting TW; Tromp J; Agarwal A; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Lagerström Fermer M; Gan LM; Lund L; Shah SJ; Lam CSP
    Eur J Heart Fail; 2022 Apr; 24(4):681-684. PubMed ID: 35060248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary Microcirculation in Heart Failure with Preserved Systolic Function.
    Vasiljevic Z; Krljanac G; Zdravkovic M; Lasica R; Trifunovic D; Asanin M
    Curr Pharm Des; 2018; 24(25):2960-2966. PubMed ID: 29992878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction.
    Tam MC; Lee R; Cascino TM; Konerman MC; Hummel SL
    Curr Hypertens Rep; 2017 Feb; 19(2):12. PubMed ID: 28233237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design.
    Ali D; Callan N; Ennis S; Powell R; McGuire S; McGregor G; Weickert MO; Miller MA; Cappuccio FP; Banerjee P
    BMJ Open; 2019 Nov; 9(11):e027984. PubMed ID: 31748285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
    Sinha A; Rahman H; Perera D
    Curr Opin Cardiol; 2023 Nov; 38(6):521-526. PubMed ID: 37668191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis.
    Lin X; Wu G; Wang S; Huang J
    Heart Fail Rev; 2024 Mar; 29(2):405-416. PubMed ID: 37870703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Metabolic-Inflammatory Circuit in Heart Failure With Preserved Ejection Fraction.
    Yap EP; Kp MMJ; Ramachandra CJ
    Curr Heart Fail Rep; 2022 Jun; 19(3):63-74. PubMed ID: 35403986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
    Paulus WJ; Dal Canto E
    JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.